参考文献/References:
[1] SIEGEL R L,MILLER K D,JEMAL A. Cancer statistics,2020[J]. CA:A Cancer Journal Clinicians,2020,70:7-30.
[2]CULP M B,SOERJOMATARAM I,EFSTATHIOU J A,et al. Recent global patterns in prostate cancer incidence and mortality rates[J]. European Urology,2020,77(1):38-52.
[3]GU X Y,ZHENG R S,XIA C F,et al. Interactions between life expectancy and the incidence and mortality rates of cancer in China:a population-based cluster analysis[J]. Cancer Communications,2018,38(1):44.
[4]LIU X G,MOUSSA C. Regulatory role of ubiquitin specific protease-13(USP13)in misfolded protein clearance in neurodegenerative diseases[J]. Neuroscience,2021,460:161-166.
[5]DIKIC I,WAKATSUKI S,WALTERS K J. Ubiquitin-binding domains-from structures to functions[J]. Nature Reviews Molecular Cell Biology,2009,10(10):659-671.
[6]SCORTEGAGNA M,SUBTIL T,QI J F,et al. USP13 enzyme regulates Siah2 ligase stability and activity via noncatalytic ubiquitin-binding domains[J]. Journal of Bioligical Chemistry,2011,286(31):27333-27341.
[7]BONNET J,ROMIER C,TORA L,et al. Zinc-finger UBPs:regulators of deubiquitylation[J]. Trends in Biochemical Sciences,2008,33(8):369-375.
[8]ZHANG J S,ZHANG P J,WEI Y K,et al. Deubiquitylation and stabilization of PTEN by USP13[J]. Nature Cell Biology,2013,15(12):1486-1494.
[9]QU Z,ZHANG R,SU M,et al. USP13 serves as a tumor suppressor via the PTEN/AKT pathway in oral squamous cell carcinoma[J]. Cancer Management and Research,2019,11:9175-9183.
[10]WU Y,ZHANG Y Q,LIU C C,et al. Amplification of USP13 drives non-small cell lung cancer progression mediated by AKT/MAPK signaling[J]. Biomedicine & Pharmacotherapy,2019,114:108831.
[11]MORGAN E L,PATTERSON M R,BARBA-MORENO D,et al. The deubiquitinase(DUB)USP13 promotes Mcl-1 stabilisation in cervical cancer[J]. Oncogene,2021,40:2112-2129.
[12]陶守松,刘凯,李亚婷,等. 去泛素化酶USP13在癌症中的研究进展[J]. 军事医学,2021,45(1):76-80.
[13]SUN H,ZHANG Q,JING Y Y,et al. USP13 negatively regulates antiviral responses by deubiquitinating STING[J]. Nature Communications,2017,8:15534.
[14]LIAO X X,LI Y H,LIU J,et al. Deubiquitinase USP13 promotes extracellular matrix expression by stabilizing Smad4 in lung fibroblast cells[J]. Translational Research,2020,223:15-24.
[15]YEH H M,YU C Y,YANG H C,et al. Ubiquitin-specific protease 13 regulates IFN signaling by stabilizing STAT1[J]. Journal of Immunology,2013,191(6):3328-3336.
[16]GAO B,WANG H,LAFDIL F,et al. STAT proteins-key regulators of anti-viral responses,inflammation,and tumorigenesis in the liver[J]. Journal Hepatology,2012,57(2):430-441.
[17]HUANG S,BUCANA C D,VAN ARSDALL M,et al. Stat1 negatively regulates angiogenesis,tumorigenicity and metastasis of tumor cells[J]. Oncogene,2002,21(16):2504-2512.
[18]RYAN N,ANDERSON K,VOLPEDO G,et al. STAT1 inhibits T-cell exhaustion and myeloid derived suppressor cell accumulation to promote antitumor immune responses in head and neck squamous cell carcinoma[J]. International Journal of Cancer,2020,146(6):1717-1729.
[19]SASIDHARAN N V,TOOR S M,ALI B R,et al. Dual inhibition of STAT1 and STAT3 activation downregulates expression of PD-L1 in human breast cancer cells[J]. Expert Opinion on Therapeutic Targets,2018,22(6):547-557.
[20]CHENG Q,FENG Q,XU Y,et al. BRCC36 functions noncatalytically to promote antiviral response by maintaining STAT1 protein stability[J]. SSRN Electronic Journal,2021,51(2):296-310.
[21]ZHANG Y H,ZHOU C J,ZHOU Z R,et al. Domain analysis reveals that a deubiquitinating enzyme USP13 performs non-activating catalysis for Lys63-linked polyubiquitin[J]. PLoS One,2011,6(12):e29362.
[22]CAPPELLESSO R,MARIONI G,CRESCENZI M,et al. The prognostic role of the epithelial-mesenchymal transition markers E-cadherin and Slug in laryngeal squamous cell carcinoma[J]. Histopathology,2015,67(4):491-500.
[23]PAN C M,WANG M L,CHIOU S H,et al. Oncostatin M suppresses metastasis of lung adenocarcinoma by inhibiting SLUG expression through coordination of STATs and PIASs signalings[J]. Oncotarget,2016,7(37):60395-60406.